Scarica l'app Stockscreener
47.90
0.02%
0.010
Dopo l'orario di chiusura:
47.90
Precedente Chiudi:
$47.89
Aprire:
$47.91
Volume 24 ore:
345.35K
Relative Volume:
0.43
Capitalizzazione di mercato:
$1.23B
Reddito:
-
Utile/perdita netta:
$11.77M
Rapporto P/E:
82.80
EPS:
0.5785
Flusso di cassa netto:
$-19.23M
1 W Prestazione:
+0.10%
1M Prestazione:
+0.40%
6M Prestazione:
+229.89%
1 anno Prestazione:
+72.30%
Intervallo 1D:
$47.89
$47.92
Intervallo di 1 settimana:
$47.81
$47.92
Portata 52W:
$11.56
$48.27
Tourmaline Bio Inc Stock (TRML) Company Profile
Nome
Tourmaline Bio Inc
Settore
Industria
Telefono
646-481-9832
Indirizzo
27 WEST 24TH STREET, NEW YORK
Confronta TRML con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
47.90 | 1.23B | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-23 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-06 | Iniziato | Wedbush | Outperform |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-11-11 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-15 | Iniziato | Jefferies | Buy |
| 2023-12-04 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-17 | Iniziato | Truist | Buy |
| 2023-10-31 | Iniziato | Guggenheim | Buy |
| 2023-10-25 | Iniziato | Piper Sandler | Overweight |
| 2022-10-20 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Mostra tutto
Tourmaline Bio Inc Borsa (TRML) Ultime notizie
Why Tourmaline Bio Inc. is moving todayJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Is Tourmaline Bio Inc. stock a top pick in earnings season - newser.com
Will Tourmaline Bio Inc. benefit from macro trends2025 Analyst Calls & AI Enhanced Execution Alerts - newser.com
Will Tourmaline Bio Inc. stock outperform growth indexesWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Developing predictive dashboards with Tourmaline Bio Inc. dataTrade Analysis Summary & Short-Term Trading Alerts - newser.com
What analysts say about Tourmaline Bio Inc stockInsider Trading Compliance & Learn What Analysts Rate “Strong Buy” - earlytimes.in
How to forecast Tourmaline Bio Inc. trends using time series2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Tourmaline Bio (NASDAQ:TRML) - MarketBeat
How to read the order book for Tourmaline Bio Inc.Recession Risk & AI Optimized Trade Strategies - newser.com
Can a trend reversal in Tourmaline Bio Inc. lead to recoveryTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders - Sahm
Tourmaline Bio, Inc.Common Stock (Nasdaq:TRML) Stock Quote | Contact Us – Inside INdiana Business - FinancialContent
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Inside INdiana Business - FinancialContent
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc.TRML - FinancialContent
Custom strategy builders for tracking Tourmaline Bio Inc.Fed Meeting & Daily Growth Stock Tips - newser.com
Using flow based indicators on Tourmaline Bio Inc.2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Sees Large Decline in Short Interest - MarketBeat
Is Tourmaline Bio Inc. forming a bottoming baseWatch List & Fast Entry Momentum Alerts - newser.com
What MACD signals say about Tourmaline Bio Inc.Portfolio Performance Report & Accurate Technical Buy Alerts - newser.com
Can Tourmaline Bio Inc. recover in the next quarter2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Technical analysis overview for Tourmaline Bio Inc. stockJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Is Tourmaline Bio Inc. stock a buy in volatile marketsJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Hold" by Analysts - MarketBeat
Identifying reversal signals in Tourmaline Bio Inc.Earnings Risk Summary & Safe Entry Zone Tips - newser.com
Tourmaline Bio (TRML) Price Target Decreased by 14.70% to 48.90 - MSN
Novartis commences tender offer to buy Tourmaline Bio - Medical Dialogues
Tourmaline Bio stock hits 52-week high at 47.8 USD By Investing.com - Investing.com Nigeria
Tourmaline Bio stock hits 52-week high at 47.8 USD - Investing.com
Tourmaline Bio (NASDAQ:TRML) Sets New 52-Week HighHere's Why - MarketBeat
Tourmaline Bio Inc Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Novartis announces commencement of tender offer to acquire Tourmaline Bio29.09.25News - Ariva
Novartis launches tender offer for Tourmaline Bio - MarketScreener
Tourmaline Bio Inc Azioni (TRML) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):